89
Views
149
CrossRef citations to date
0
Altmetric
Original Article

Effect of Chlorothiazide and Hydrochlorothiazide on the Excretion of Calcium in Urine

&
Pages 351-357 | Received 27 Jun 1959, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Kenneth Newmark & Paul Nugent. (1993) Milk-alkali syndrome. Postgraduate Medicine 93:6, pages 149-156.
Read now
Martti Ala-Opas, Inkeri Elomaa, Leena Porkka & Olof Alfthan. (1987) Unprocessed Bran and Intermittent Thiazide Therapy in Prevention of Recurrent Urinary Calcium Stones. Scandinavian Journal of Urology and Nephrology 21:4, pages 311-314.
Read now
P. Brocks, C. Christiansen, H. Dirksen, I. Transbøl & H. Wolf. (1983) Effect of Thiazides on the Urinary Calcium Oxalate Stone-Forming Potential in Normal Males. Scandinavian Journal of Urology and Nephrology 17:3, pages 325-328.
Read now
Sverker Ljunghall, Ulla Backman, Bo G. Danielson, Bengt Fellström, Gunnar Johansson & Björn Wikström. (1981) Calcium and Magnesium Metabolism During Long-Term Treatment with Thiazides. Scandinavian Journal of Urology and Nephrology 15:3, pages 257-262.
Read now
F. Schønau Jørgensen & S. Brünner. (1974) The Long-Term Effect of Bendroflumethjazide on Renal Calcium and Magnesium Excretion and Stone Formatjon in Patients with Recurring Renal Stones. Scandinavian Journal of Urology and Nephrology 8:2, pages 128-131.
Read now
C. Moens & M. Wauters. (1966) Hypocalciuric Effect of Benzothiazides. Acta Rheumatologica Scandinavica 12:1-4, pages 228-233.
Read now

Articles from other publishers (142)

Naoya Mizutani, Ken Goda & Tsuneaki Kenzaka. (2023) A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy. Medicina 59:7, pages 1345.
Crossref
Ngoc-Yen T. Pham, Jonathan G. Owen, Namita Singh & Saeed Kamran Shaffi. (2021) The Use of Thiazide Diuretics for the Treatment of Hypertension in Patients With Advanced Chronic Kidney Disease. Cardiology in Review 31:2, pages 99-107.
Crossref
Deepa A. Malieckal, Calyani Ganesan, Denisse Arellano Mendez & Alan C. Pao. (2023) Breaking the Cycle of Recurrent Calcium Stone Disease. Advances in Kidney Disease and Health 30:2, pages 164-176.
Crossref
Hoang-Long Huynh, Lena Fan, Carmen Germosen, Mariana Bucovsky, Ivelisse Colon, Nayoung Kil, Sanchita Agarwal & Marcella Walker. (2022) Thiazide use and skeletal microstructure: Results from a multi-ethnic study. Bone Reports 16, pages 101589.
Crossref
Khashayar Sakhaee & Naim M. Maalouf. 2021. Marcus and Feldman's Osteoporosis. Marcus and Feldman's Osteoporosis 1439 1458 .
Tesfaye Getachew Charkos, Yawen Liu & Shuman Yang. (2020) Thiazide diuretics and risk of hip fracture: A Bayesian meta-analysis of cohort studies. Global Epidemiology 2, pages 100025.
Crossref
E. Letavernier. (2020) Hipercalciuria. EMC - Aparato Locomotor 53:3, pages 1-8.
Crossref
Mahmoud F. SakrMahmoud F. Sakr. 2020. Thyroid Disease. Thyroid Disease 599 662 .
Tesfaye Getachew Charkos, Yawen Liu, Lina Jin & Shuman Yang. (2019) Thiazide Use and Fracture Risk: An updated Bayesian Meta-Analysis. Scientific Reports 9:1.
Crossref
H. Taipale, J. Rysä, J. Hukkanen, M. Koponen, A. Tanskanen, J. Tiihonen, H. Kröger, S. Hartikainen & A.-M. Tolppanen. (2019) Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer’s disease—nested case-control study. Osteoporosis International 30:7, pages 1481-1489.
Crossref
Kristina L. Penniston & Stephen Y. Nakada. (2018) Updates in the Metabolic Management of Calcium Stones. Current Urology Reports 19:6.
Crossref
Emily Mohn, Hua Kern, Edward Saltzman, Susan Mitmesser & Diane McKay. (2018) Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics 10:1, pages 36.
Crossref
Gregory R. Emkey & Sol Epstein. 2018. Vitamin D. Vitamin D 331 374 .
Joshua I. Barzilay, Barry R. Davis, Sara L. Pressel, Alokananda Ghosh, Rachel Puttnam, Karen L. Margolis & Paul K. Whelton. (2017) The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk. Current Cardiology Reports 19:9.
Crossref
Bart L. Clarke. 2017. Medical and Surgical Treatment of Parathyroid Diseases. Medical and Surgical Treatment of Parathyroid Diseases 115 127 .
Julie M. Paik, Harold N. Rosen, Catherine M. Gordon & Gary C. Curhan. (2016) Diuretic Use and Risk of Vertebral Fracture in Women. The American Journal of Medicine 129:12, pages 1299-1306.
Crossref
Damayanthi Devineni, Nicole Vaccaro, David Polidori, Sarah Rusch & Ewa Wajs. (2014) Effects of Hydrochlorothiazide on the Pharmacokinetics, Pharmacodynamics, and Tolerability of Canagliflozin, a Sodium Glucose Co-transporter 2 Inhibitor, in Healthy Participants. Clinical Therapeutics 36:5, pages 698-710.
Crossref
John J. Knoedler & Amy E. Krambeck. 2014. Practical Controversies in Medical Management of Stone Disease. Practical Controversies in Medical Management of Stone Disease 131 141 .
Kristin J. Bergsland, Elaine M. Worcester & Fredric L. Coe. (2013) Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. American Journal of Physiology-Renal Physiology 305:4, pages F592-F599.
Crossref
Jianghui Hou. (2012) The Role of Claudin in Hypercalciuric Nephrolithiasis. Current Urology Reports 14:1, pages 5-12.
Crossref
B.E. Christopher Nordin. 2013. Osteoporosis. Osteoporosis 31 50 .
Laura E. Ryan & Steven W. Ing. (2012) Idiopathic Hypercalciuria and Bone Health. Current Osteoporosis Reports 10:4, pages 286-295.
Crossref
KoKo Aung & Thwe Htay. (2011) Thiazide diuretics and the risk of hip fracture. Cochrane Database of Systematic Reviews.
Crossref
John P Bilezikian, Aliya Khan, John T PottsJrJr, Maria Luisa Brandi, Bart L Clarke, Dolores Shoback, Harald Jüppner, Pierre D'Amour, John Fox, Lars Rejnmark, Leif Mosekilde, Mishaela R Rubin, David Dempster, Rachel Gafni, Michael T Collins, Jim Sliney & James Sanders. (2011) Hypoparathyroidism in the adult: Epidemiology, diagnosis, pathophysiology, target‐organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research 26:10, pages 2317-2337.
Crossref
Rebecca Vigen, Rick A. Weideman & Robert F. Reilly. (2010) Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?. International Urology and Nephrology 43:3, pages 813-819.
Crossref
Ji Na Choi, Jae Seung Lee & Jae Il Shin. (2011) Low‐dose thiazide diuretics in children with idiopathic renal hypercalciuria. Acta Paediatrica 100:8.
Crossref
Babar Parvez, Chinenye Emuwa, Marquetta L. Faulkner & John J. Murray. (2011) Milk Alkali and Hydrochlorothiazide: A Case Report. Case Reports in Medicine 2011, pages 1-4.
Crossref
Barrie M. Weinstein & Sol Epstein. 2011. Vitamin D. Vitamin D 1245 1290 .
Robert F. Reilly, Aldo J. Peixoto & Gary V. Desir. (2010) The Evidence-Based Use of Thiazide Diuretics in Hypertension and Nephrolithiasis. Clinical Journal of the American Society of Nephrology 5:10, pages 1893-1903.
Crossref
B.E. CHRISTOPHER NORDIN. 2008. Osteoporosis. Osteoporosis 47 69 .
S. F. J. van de Graaf, R. J. M. Bindels & J. G. J. Hoenderop. 2007. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology 77 160 .
Arjen R Mensenkamp, Joost GJ Hoenderop & René JM Bindels. (2006) Recent advances in renal tubular calcium reabsorption. Current Opinion in Nephrology & Hypertension 15:5, pages 524-529.
Crossref
KoKo Aung & Thwe Htay. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
SOL EPSTEIN & ADINA E. SCHNEIDER. 2005. Vitamin D. Vitamin D 1253 1291 .
L. Rejnmark, P. Vestergaard, A. R. Pedersen, L. Heickendorff, F. Andreasen & L. Mosekilde. (2003) Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. European Journal of Clinical Investigation 33:1, pages 41-50.
Crossref
Chul-Hee Kim, San W. Kim & Ghi S. Kim. (2000) Effects of hydrochlorothiazine and furosemide diuretics on human bone marrow stromal osteoprogenitor cells. Metabolism 49:1, pages 17-21.
Crossref
Ira Kurtz, Jordan J. Cohen, John T. Harrington, Nicolaos E. Madias & Cheryl J. Zusman. (1998) Molecular pathogenesis of Bartter’s and Gitelman’s syndromes. Kidney International 54:4, pages 1396-1410.
Crossref
John P. Barcia, C. Frederic Strife & Craig B. Langman. (1997) Infantile hypophosphatasia: Treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. The Journal of Pediatrics 130:5, pages 825-828.
Crossref
Long-Jun Dai, Peter A. Friedman & Gary A. Quamme. (1997) Cellular mechanisms of chlorothiazide and cellular potassium depletion on Mg2+ uptake in mouse distal convoluted tubule cells. Kidney International 51:4, pages 1008-1017.
Crossref
Khashayar Sakhaee. 1997. Diuretic Agents. Diuretic Agents 595 609 .
D. Feskanich, W. C. Willett, M. J. Stampfer & G. A. Colditz. (1997) A prospective study of thiazide use and fractures in women. Osteoporosis International 7:1, pages 79-84.
Crossref
K. -H. W. Lau, X. D. Song, M. Ochi & J. E. Wergedal. (1996) Mitogenic action of hydrochlorothiazide on human osteoblasts In vitro: Requirement for platelet-derived growth factor. Calcified Tissue International 59:6, pages 505-510.
Crossref
B.E. Christopher Nordin, Barry E. Chatterton, Allan G. Need & Michael Horowitz. (1995) The Definition, Diagnosis, and Classification of Osteoporosis. Physical Medicine and Rehabilitation Clinics of North America 6:3, pages 395-414.
Crossref
R. D. Wasnich, J. W. Davis, Y. -F. He, H. Petrovich & P. D. Ross. (1995) A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women. Osteoporosis International 5:4, pages 247-251.
Crossref
H. Velázquez, H. Knauf & E. Mutscler. 1995. Diuretics. Diuretics 275 334 .
G. Jones Menzies, Tuan Nguyen, Philip N. Sambrook & John A. Eisman. (2009) Thiazide diuretics and fractures: Can meta‐analysis help?. Journal of Bone and Mineral Research 10:1, pages 106-111.
Crossref
B.E. Christopher Nordin, Allan G. Need, Michael Horowitz & Howard A. Morris. (1994) Treatment of Osteoporosis in The Elderly. Clinics in Geriatric Medicine 10:4, pages 625-646.
Crossref
T. J. Hall & M. Schaueblin. (1994) Hydrochlorothiazide inhibits osteoclastic bone resorption In vitro. Calcified Tissue International 55:4, pages 266-268.
Crossref
Gy�rgy S. Reusz, Mariann Dobos, Tivadar Tulassay & Mikl�s Milt�nyi. (1993) Hydrochlorothiazide treatment of children with hypercalciuria: effects and side effects. Pediatric Nephrology 7:6, pages 699-702.
Crossref
Horace M. PerryIIIIII, Judy Jensen, Fran E. Kaiser, Michael Horowitz, H. Mitchell PerryJr.Jr. & John E. Morley. (1993) The Effects of Thiazide Diuretics on Calcium Metabolism in the Aged. Journal of the American Geriatrics Society 41:8, pages 818-822.
Crossref
Bess Dawson-Hughes & Susan Harris. (1993) Thiazides and seasonal bone change in healthy postmenopausal women. Bone and Mineral 21:1, pages 41-51.
Crossref
Edward M. Brown. 2011. Comprehensive Physiology. Comprehensive Physiology 1841 1916 .
Linda S. Costanzo & Erich E. Windhager. 2011. Comprehensive Physiology. Comprehensive Physiology 1759 1783 .
J Staessen, A Amery, A Bernard, P Bruaux, J P Buchet, F Claeys, P De Plaen, G Ducoffre, R Fagard & R R Lauwerys. (1991) Effects of exposure to cadmium on calcium metabolism: a population study.. Occupational and Environmental Medicine 48:10, pages 710-714.
Crossref
Ignac Fogelman. (1991) Thiazide diuretics and osteoporosis. International Journal of Clinical Practice 45:3, pages 174-175.
Crossref
D. Lajeunesse & M. G. Brunette. (1991) The hypocalciuric effect of thiazides: subcellular localization of the action. Pfl�gers Archiv European Journal of Physiology 417:5, pages 454-462.
Crossref
Jean C. Scott. (1990) Osteoporosis and Hip Fractures. Rheumatic Disease Clinics of North America 16:3, pages 717-740.
Crossref
J. Dequeker & P. Geusens. (1990) Treatment of established osteoporosis and rehabilitation: current practice and possibilities. Maturitas 12:1, pages 1-36.
Crossref
A. Halabe, N. L. M. Wong & R. A. L. Sutton. (1990) The effect of verapamil and thiazide in the prevention of renal stone formation. Urological Research 18:2, pages 155-158.
Crossref
Andrea Z. LaCroix, Jan Wienpahl, Lon R. White, Robert B. Wallace, Paul A. Scherr, Linda K. George, Joan Cornoni-Huntley & Adrian M. Ostfeld. (1990) Thiazide Diuretic Agents and the Incidence of Hip Fracture. New England Journal of Medicine 322:5, pages 286-290.
Crossref
I F Hunt, N J Murphy, C Henderson, V A Clark, R M Jacobs, P K Johnston & A H Coulson. (1989) Bone mineral content in postmenopausal women: comparison of omnivores and vegetarians. The American Journal of Clinical Nutrition 50:3, pages 517-523.
Crossref
U. Krause, A. Zielke, H. Schmidt-Gayk, W. Ehrenthal & J. Beyer. (2014) Direct tubular effect on calcium retention by hydrochlorothiazide. Journal of Endocrinological Investigation 12:8, pages 531-535.
Crossref
J. E. MorleyDr.Dr., M. J. Gorbien, A. D. Mooradian, A. J. Silver, A. S. Brickman & F. E. Kaiser. (1988) UCLA Geriatric Grand Rounds: Osteoporosis. Journal of the American Geriatrics Society 36:9, pages 845-859.
Crossref
M. Peacock. 1988. Calcium in Human Biology. Calcium in Human Biology 125 169 .
Leonard C. Hymes & Barry L. Warshaw. (1987) Thiazide Diuretics for the Treatment of Children With Idiopathic Hypercalciuria and Hematuria. Journal of Urology 138:5, pages 1217-1219.
Crossref
Fernando Santos & James C. M. Chan. 1987. Diuretics: Basic, Pharmacological, and Clinical Aspects. Diuretics: Basic, Pharmacological, and Clinical Aspects 453 455 .
K. Matsushita, K. Tanikawa & N. Kawamura. 1987. Diuretics: Basic, Pharmacological, and Clinical Aspects. Diuretics: Basic, Pharmacological, and Clinical Aspects 444 446 .
J. T. Mortensen, A. Schultz & A. H. Østergaard. (1986) Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. International Urology and Nephrology 18:3, pages 265-269.
Crossref
Louis B. Gaker & Nicholas Butcher. (1986) Dissolution of Staghorn Calculus Associated with Amiloride-Hydrochlorothiazide, Sulfamethoxazole and Trimethoprim, and Ascorbic Acid. Journal of Urology 135:5, pages 993-994.
Crossref
Björn Beermann. (2009) THIAZIDES AND LOOP‐DIURETICS THERAPEUTIC ASPECTS. Acta Medica Scandinavica 219:S707, pages 75-78.
Crossref
Wolfgang Tschöpe, Reinhold Horsch & Eberhard Ritz. 1986. Phosphate and Mineral Homeostasis. Phosphate and Mineral Homeostasis 459 465 .
Daniel C. Batlle, Wu-Chang Yang, Alisa Von Riotte & Salim K. Mujais. 1986. Phosphate and Mineral Homeostasis. Phosphate and Mineral Homeostasis 433 441 .
Bente Riis & Claus Christiansen. (1985) Actions of thiazide on vitamin D metabolism: A controlled therapeutic trial in normal women early in the postmenopause. Metabolism 34:5, pages 421-424.
Crossref
Roger A.L. Sutton. (1985) Diuretics and Calcium Metabolism. American Journal of Kidney Diseases 5:1, pages 4-9.
Crossref
Jørgen Christoffersen & Margaret R. Christoffersen. (1984) The effect of bendroflumethiazide and hydrochlorothiazide on the rate of dissolution of calcium hydroxyapatite. Calcified Tissue International 36:1, pages 431-434.
Crossref
Inkeri Elomaa, Martti Ala-Opas & Leena Porkka. (1984) Five Years of Experience with Selective Therapy in Recurrent Calcium Nephrolithiasis. Journal of Urology 132:4, pages 656-661.
Crossref
EVEN LÆRUM & STIG LARSEN. (2009) Thiazide Prophylaxis of Urolithiasis. Acta Medica Scandinavica 215:4, pages 383-389.
Crossref
J. Dequeker, P. Geusens & A. Verstraeten. 1984. The Climacteric: An Update. The Climacteric: An Update 157 179 .
F. Krück. 1984. Herzinsuffizienz. Herzinsuffizienz 719 775 .
P. May, H. Pilorz, C. Duhme, B. Lux, J. Braun & H. Pöpperl. 1984. Pathogenese und Klinik der Harnsteine X. Pathogenese und Klinik der Harnsteine X 508 512 .
U. Dunzendorfer, E. Werner, H. Hahn & W. Weber. 1984. Pathogenese und Klinik der Harnsteine X. Pathogenese und Klinik der Harnsteine X 492 498 .
Roger A. L. Sutton. 1984. Nephrology. Nephrology 999 1010 .
Richard D. Wasnich, Richard J. Benfante, Katsuhiko Yano, Lance Heilbrun & John M. Vogel. (1983) Thiazide Effect on the Mineral Content of Bone. New England Journal of Medicine 309:6, pages 344-347.
Crossref
Roger A.L. Sutton. (1983) Disorders of renal calcium excretion. Kidney International 23:5, pages 665-673.
Crossref
Inkeri Elomaa, Arto Sivula, Arvi Kahri, Liisa Puutula-Räsänen & Risto Pelkonen. (1983) Hyperparathyroidism with hypercalciuria and urolithiasis: Long-term effects of parathyroid surgery and postoperative thiazide therapy. World Journal of Surgery 7:2, pages 186-193.
Crossref
Herbert KlosterhalfenM. Hegemann, R. Pfab, I. Böttger, E. Llanos & W. Schütz. 1983. 20. bis 23. Oktober 1982, Hamburg. 20. bis 23. Oktober 1982, Hamburg 343 346 .
Paul J. Cannon. 1983. Cardiac therapy. Cardiac therapy 413 434 .
Dieter Scholz, Paul Otto Schwille & Alfred Sigel. (1982) Double-Blind Study with Thiazide in Recurrent Calcium Lithiasis. Journal of Urology 128:5, pages 903-907.
Crossref
I. Transbøl, M.S. Christensen, G.F. Jensen, C. Christiansen & P. McNair. (1982) Thiazide for the postponement of postmenopausal bone loss. Metabolism 31:4, pages 383-386.
Crossref
SHAUL G. MASSRY. 1982. Disorders of Mineral Metabolism. Disorders of Mineral Metabolism 189 235 .
Wolfgang Tschöpe, Ludwig Knebel, Eberhard Ritz & Dietrich Dietlein. 1982. Pathogenese und Klinik der Harnsteine IX. Pathogenese und Klinik der Harnsteine IX 372 378 .
Wadi N. Suki. 1982. Regulation of Phosphate and Mineral Metabolism. Regulation of Phosphate and Mineral Metabolism 493 500 .
Peter Brocks, Claus Dahl, Hans Wolf & Ib Transbøl. (1981) DO THIAZIDES PREVENT RECURRENT IDIOPATHIC RENAL CALCIUM STONES?. The Lancet 318:8238, pages 124-125.
Crossref
John S. Adams, Timothy O. Wahl & Barbara P. Lukert. (1981) Effects of hydrochlorothiazide and dietary sodium restriction on calcium metabolism in corticosteroid treated patients. Metabolism 30:3, pages 217-221.
Crossref
J.S.H. Rundle & Roy Scott. (1980) Intermittent thiazide therapy in recurrent stone formers. Urology 16:5, pages 464-466.
Crossref
Thomas F. Knight, Harry O. Senekjian, Kent Taylor, Deborah A. Steplock & Edward J. Weinman. (1979) Renal transport of oxalate: Effects of diuretics, uric acid, and calcium. Kidney International 16:5, pages 572-576.
Crossref
U. BACKMAN, B. G. DANIELSON, G. JOHANSSON, S. LJUNGHALL & B. WIKSTROM. (1979) Effects of Therapy with Bendroflumethiazide in Patients with Recurrent Renal Calcium Stones. British Journal of Urology 51:3, pages 175-180.
Crossref
Leslie N. PyrahLeslie N. Pyrah. 1979. Renal Calculus. Renal Calculus 151 165 .
A. Goulding, G. F. S. Spears & F. O. Simpson. (2008) Effects of Different Diuretics on Urinary Calcium Excretion in a General Population. Australian and New Zealand Journal of Medicine 8:5, pages 474-478.
Crossref
Robert Marcus, Francine Orner, Gregory Arvesen & Christopher Lundquist. (1978) Thiazide diuretics do not potentiate cAMP response to parathyroid hormone. Metabolism 27:6, pages 701-710.
Crossref
Edmund R. Yendt & Moussa Cohanim. (1978) Prevention of calcium stones with thiazides. Kidney International 13:5, pages 397-409.
Crossref
Robert H. Porter, Brian G. Cox, David Heaney, Thomas H. Hostetter, Bobby J. Stinebaugh & Wadi N. Suki. (1978) Treatment of Hypoparathyroid Patients with Chlorthalidone. New England Journal of Medicine 298:11, pages 577-581.
Crossref
JOEL F. HABENER & JOHN T. POTTSJR.JR.. 1978. Metabolic Bone Disease. Metabolic Bone Disease 1 147 .
Charles Y. C. PakCharles Y. C. Pak. 1978. Calcium Urolithiasis. Calcium Urolithiasis 37 79 .
Lars Thor�n. (1977) Hyperparathyroidism with asymptomatic hypercalcemia and symptomatic normocalcemia. World Journal of Surgery 1:6, pages 739-743.
Crossref
Herbert G. Langford, Robert L. Watson & Jeanne Gouras Thomas. (1977) Salt intake and the treatment of hypertension. American Heart Journal 93:4, pages 531-532.
Crossref
Alan Woelfel, Roy A. Kaplan & Charles Y.C. Pak. (1977) Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine. Metabolism 26:2, pages 201-205.
Crossref
OLAV L.M. BIJVOET. 1977. Metabolic Bone Disease. Metabolic Bone Disease 49 140 .
Neil Breslau, Arnold M. Moses & I.M. Weiner. (1976) The role of volume contraction in the hypocalciuric action of chlorothiazide. Kidney International 10:2, pages 164-170.
Crossref
Garabed Eknoyan, Manuel Martinez-Maldonado & Wadi N. Suki. 1976. Methods in Pharmacology. Methods in Pharmacology 99 119 .
N. J. BLACKLOCK & M. A. MACLEOD. (2008) The Effect of Cellulose Phosphate on Intestinal Absorption and Urinary Excretion of Calcium: Some Experience in its use in the Treatment of Calcium Stone Formation. British Journal of Urology 46:4, pages 385-392.
Crossref
Ulrich Ehrig, Joan E. Harrison & Douglas R. Wilson. (1974) Effect of long-term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi. Metabolism 23:2, pages 139-149.
Crossref
F. Schønau Jørgensen & Ib Transbøl. (2009) THE EFFECT OF BENDROFLUMETHIAZIDE ON THE INTESTINAL ABSORPTION OF CALCIUM IN NORMOCALCAEMIC RENAL STONE FORMERS AND IN HYPERPARATHYROIDISM. Acta Medica Scandinavica 195:1-6, pages 33-36.
Crossref
Melvin J. Fregly & Jeane S. McCarthy. (1973) Effect of diuretics on renal iodide excretion by humans. Toxicology and Applied Pharmacology 25:2, pages 289-298.
Crossref
Stewart Middler, Charles Y.C. Pak, Ferid Murad & Frederic C. Bartter. (1973) Thiazide diuretics and calcium metabolism. Metabolism 22:2, pages 139-146.
Crossref
F. Schønau Jørgensen & Ib Transbøl. (2009) THE EFFECT OF BENDROFLUMETHIAZIDE ON THE RENAL HANDLING OF CALCIUM, MAGNESIUM AND PHOSPHATE IN NORMOCALCAEMIC RENAL STONE FORMERS AND IN HYPERPARATHYROIDISM. Acta Medica Scandinavica 194:1-6, pages 327-334.
Crossref
F. Schønau Jørgensen, Ib Transbøl & Chr. Binder. (2009) THE EFFECT OF BENDROFLUMETHIAZIDE ON TOTAL, ULTRAFILTRABLE AND IONIZED CALCIUM IN SERUM IN NORMOCALCAEMIC RENAL STONE FORMERS AND IN HYPERPARATHYROIDISM. Acta Medica Scandinavica 194:1-6, pages 323-326.
Crossref
Seppo Lindy & Leo Tarssanen. (2009) SERUM CALCIUM AND PHOSPHORUS IN PATIENTS TREATED WITH THIAZIDES AND FUROSEMIDE. Acta Medica Scandinavica 194:1-6, pages 319-322.
Crossref
K. MiehlkeH. Loew & H. Wagner. 1973. Neunundsiebzigster Kongress. Neunundsiebzigster Kongress 741 743 .
F. Schønau Jørgensen & S. Pors Nielsen. (2009) Effects of Long-Term Administration of Bendroflumethiazide on Bone Metabolism in the Rat. Acta Pharmacologica et Toxicologica 31:5-7, pages 521-528.
Crossref
F. Schønau Jøergensen. (1972) Effect of a Single, Large Intramuscular Dose of Bendroflumethiazide (Centyl®) on Calcium Metabolism in Rats. Acta Pharmacologica et Toxicologica 31:3, pages 170-176.
Crossref
B.E.C. Nordin, M. Peacock & R. Wilkinson. (1972) Hypercalciuria and calcium stone disease. Clinics in Endocrinology and Metabolism 1:1, pages 169-183.
Crossref
Fritz Schønau Jørgensen. (2009) The Effect of Bendroflumethiazide (Centyl®) on the Renal Excretion of Calcium and Sodium in Normal, Parathyroidectomized, Thyroidectomized and Thyroparathyroidectomized Rats. Acta Pharmacologica et Toxicologica 30:3-4, pages 296-307.
Crossref
Cristobal G. Duarte, John L. Winnacker, Kenneth L. Becker & Angelo Pace. (1971) Thiazide-Induced Hypercalcemia. New England Journal of Medicine 284:15, pages 828-830.
Crossref
Ranjit Singh Nanra, J. A. Tambayah & Priscilla Kincaid‐Smith. (1969) CALCIUM EXCRETION IN PATIENTS WITH RENAL ALLOGRAFTS. Medical Journal of Australia 2:19, pages 952-955.
Crossref
Jack R. Pickleman, Francis H. StrausIIII, Marvin Forland & Edward Paloyan. (1969) Thiazide-induced parathyroid stimulation. Metabolism 18:10, pages 867-873.
Crossref
K. V. JOHNY, J. R. LAWRENCE & M. W. O'HALLORAN. (1969) AMILORIDE HYDROCHLORIDE, A HYPERCALCIURIC DIURETIC. Australasian Annals of Medicine 18:3, pages 267-270.
Crossref
MACKENZIE WALSER. 1969. Calcium Physiology. Calcium Physiology 235 320 .
D. Szadkowski, B. Weimershaus, K. Lindner, K. H. Schaller & G. Lehnert. (1969) Einflu� von Aldosteron auf den Interflux und Efflux arbeitsmedizinisch relevanter Mineralien und Spurenelemente des menschlichen OrganismusInfluence of aldosterone on the metabolism of some minerals and trace minerals with regard to occupational medicine. Internationale Zeitschrift f�r Angewandte Physiologie Einschlie�lich Arbeitsphysiologie 27:2, pages 99-109.
Crossref
G. Peters & Françoise Roch-Ramel. 1969. Diuretica. Diuretica 257 385 .
Cristobal G. Duarte. (1968) Effects of ethacrynic acid and furosemide on urinary calcium, phosphate and magnesium. Metabolism 17:10, pages 867-876.
Crossref
Cristobal G. Duarte. (1968) Effects of Chlorothiazide and Amipramizide (MK 870) on the renal excretion of calcium, phosphate and magnesium. Metabolism 17:5, pages 420-429.
Crossref
Hans Jesserer. 1968. Nierenkrankheiten. Nierenkrankheiten 909 969 .
Cristobal G. Duarte & John H. Bland. (1965) Calcium, phosphorus and uric acid clearances after intravenous administration of chlorothiazide. Metabolism 14:3, pages 211-219.
Crossref
F.B. Steiner. (1965) SOME ASPECTS OF HYPOGLYCÆMIA. The Lancet 285:7383, pages 490.
Crossref
B.-A. Lamberg, P. Torsti & J. Paloheimo. (1965) URINARY SODIUM/POTASSIUM RATIO AFTER CHLOROTHIAZIDE IN ADDISON'S DISEASE. The Lancet 285:7383, pages 490.
Crossref
Oto Küchel, Karel Horký, Milan Pazourek & Inge Gregorová. (1965) DANGERS OF ANGIOTENSIN. The Lancet 285:7383, pages 489-490.
Crossref
B.-A. Lamberg, J. Paloheimo & P. Torsti. (2009) Changes in the Urinary Excretion of Calcium after Intravenous Injection of Aldosterone. Acta Medica Scandinavica 175, pages 205-213.
Crossref
B.-A. Lamberg & P. Torsti. (2009) The Dependence of Calcium Excretion on Adrenal Steroids. Acta Medica Scandinavica 175, pages 193-203.
Crossref
P. Torsti & B.-A. Lamberg. (2009) The Effect of a Two-day Treatment with Chlorothiazide on the Urinary Excretion of Calcium, Phosphate and Sodium in Hyper- and Hypocalcaemia. Acta Medica Scandinavica 175, pages 181-191.
Crossref
MACKENZIE WALSER & BRIAN H.B. ROBINSON. 1963. The Transfer of Calcium and Strontium Across Biological Membranes. The Transfer of Calcium and Strontium Across Biological Membranes 305 326 .
John W. Poutsiaka, Harry Madissoo, Lloyd G. Millstein & John Kirpan. (1961) Effects of benzydroflumethiazide (naturetin) on the renal excretion of calcium and magnesium by dogs. Toxicology and Applied Pharmacology 3:4, pages 455-458.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.